Indoco Remedies (NSE:INDOCO) EV-to-FCF: (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INDOCO Indoco Remedies Ltd NSE:INDOCO
68 GF Score
Price ₹249.57
GF Value ₹361.83
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Indoco Remedies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Indoco Remedies's Enterprise Value is ₹33,328 Mil. Indoco Remedies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil. Therefore, Indoco Remedies's EV-to-FCF for today is .

The historical rank and industry rank for Indoco Remedies's EV-to-FCF or its related term are showing as below:

NSE:INDOCO' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 34.01
Current: 34.01

During the past 13 years, the highest EV-to-FCF of Indoco Remedies was 34.01. The lowest was 0.00. And the median was 0.00.

NSE:INDOCO's EV-to-FCF is ranked worse than
62.7% of 563 companies
in the Drug Manufacturers industry
Industry Median: 21.03 vs NSE:INDOCO: 34.01

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-16), Indoco Remedies's stock price is ₹249.57. Indoco Remedies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-10.710. Therefore, Indoco Remedies's PE Ratio (TTM) for today is At Loss.


Indoco Remedies  (NSE:INDOCO) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Indoco Remedies's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=249.57/-10.710
=At Loss

Indoco Remedies's share price for today is ₹249.57.
Indoco Remedies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-10.710.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Indoco Remedies EV-to-FCF Related Terms


Indoco Remedies EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Indoco Remedies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indoco Remedies EV-to-FCF Chart

Indoco Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 75.97 -116.73 -13.58 -18.64 25.31

Indoco Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.64 0.00 0.00 0.00 25.31

NSE:INDOCO vs ZTS, UTHR: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Indoco Remedies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indoco Remedies EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indoco Remedies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Indoco Remedies's EV-to-FCF falls into.


NSE:INDOCO
68GF Score
Indoco Remedies Ltd NSE:INDOCO
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indoco Remedies EV-to-FCF Calculation

Indoco Remedies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=33327.870/0
=

Indoco Remedies's current Enterprise Value is ₹33,328 Mil.
Indoco Remedies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Indoco Remedies (NSE:INDOCO) Overvalued in 2026?

Based on GuruFocus' analysis, Indoco Remedies stock appears to be undervalued. The current stock price of ₹249.57 is trading 31% below its estimated GF Value™ of ₹361.83. GuruFocus considers Indoco Remedies to be Possible Value Trap.

Key valuation signals for NSE:INDOCO:

  • EV-to-FCF:
  • GF Value™: ₹361.83 vs. price of ₹249.57 (31% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the NSE:INDOCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Indoco Remedies Business Description

Other Exchanges 532612:India
Address 166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.
68GF Score

Get the complete analysis for NSE:INDOCO

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹249.57
Price
₹361.83
GF Value